Overview
FrançaisABSTRACT
The processes of mass cultivation of animal cells are at the moment increasingly used in the biotechnological and pharmaceutical industry. The capabilities of these cells to produce viral particles and complex recombinant molecules have opened interesting paths in order to meet the numerous challenges in the public health sector. However, the industrial implementation of such processes requires the transferal of the cultivation of the cells from the scale of the box to that of the reactor without impacting the productivity or the quality of the product. The aim of this article is to enable the layman to grasp the specificities of these products. It encompasses the notions concerning the used cells and cultivation media, as well as the evolution of cellular behavior according to environmental conditions. It presents bioreactor technologies as well as control strategies and the implementation of semi-continuous and perfused processes. It finally introduces elements related to hydrodynamics and matter transfer involved in these processes.
Read this article from a comprehensive knowledge base, updated and supplemented with articles reviewed by scientific committees.
Read the articleAUTHORS
-
Annie MARC: Research Director, CNRS - Reactions and Process Engineering Laboratory – UPR CNRS 3349, Nancy-Université
-
Éric OLMOS: Senior lecturer at ENSAIA, Nancy - Reactions and Process Engineering Laboratory – UPR CNRS 3349, Nancy-Université
INTRODUCTION
Mass-culture processes for animal cells have made considerable progress over the last 30 years. They have thus become essential to the biotechnology industries for the production of numerous products with therapeutic and diagnostic applications (viral vaccines, cytokines, growth factors, monoclonal antibodies, recombinant proteins, etc.). These products are used to prevent or treat diseases such as cancer, viral infections, hereditary deficiencies and many chronic illnesses. This acceleration means that production capacity has to be increased. There are now more than fifteen installations using stainless steel stirred-tank reactors of the order of 15,000 liters. More specialized production uses smaller but more diversified systems. Recently, there has been a strong interest in single-use reactors, as links in the production chain or for screening operating conditions. As far as investments are concerned, given the long lead-times for installation and validation of an industrial unit, these must be anticipated as early as possible, based on upstream knowledge and high-performance decision-support tools.
The feasibility of industrial production of a bioproduct using animal cells requires the transfer of cell culture to reactor scale, without loss of production performance and quality. The challenge is to use relatively fragile cells under conditions of environmental, biochemical and physical stress, while maintaining their production potential. This calls for an integrated, multi-scale approach that takes into account aspects relating to bioreactors, cell characteristics and product quality. The challenges to be met combine knowledge of cellular processes in relation to the culture medium, adaptation of cells to reactor constraints, formulation of culture media, research into cell and product analysis tools to improve on-line process control, design of new reactors, control of operating conditions and identification of key extrapolation parameters. This necessarily involves an interdisciplinary approach between life sciences and process engineering.
Against this backdrop, this article sets out to present the main specificities of animal cell culture processes. After outlining the characteristics of the most commonly used industrial cell lines, we will discuss the current challenges facing culture media and provide data on the impact of operating factors on cell behavior. Another section will focus on reactor technologies, both conventional and single-use, as well as tools for controlling and operating these processes. Finally, elements relating to hydrodynamics and material transfer encountered in these processes will be presented.
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Healthcare technologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Mass culture processes for animal cells
Bibliography
Websites
LEEM study. Bioproduction in 2008: state of play and recommendations for French attractiveness. http://www.leem.org/dossier/101/etude-bioproduction-en-2008-etat-des-lieux-et-recommandations-pour-l-attractivite-1297.htm
Events (non-exhaustive list)
ESACT Congress, held every two years in Europe http://www.esact.org/meetings_esact.html
Congress of the engineering foundation: cell culture engineering, held every two years, mainly in the U.S.
Directory
Organizations – Federations – Associations (non-exhaustive list)
ESACT Association: European Society of Animal Cell Technology http://www.esact.org/
Association ACTIP: Animal Cell Technology Industrial Platform http://www.actip.org/
Training courses...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference